Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 1
2007 2
2008 2
2009 3
2010 2
2012 3
2013 3
2014 3
2015 2
2016 2
2020 1
2023 1
2024 3
2025 2
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Indications and Treatment Outcomes of Below-the-Knee Peripheral Artery Interventions in the XLPAD Registry.
Rosol ZP, Sayfo S, Fernandez-Vazquez D, Jeong M, Mamawala M, Gupta A, Bruneman BM, Weideman SG, Adelman KS, Tsai S, Nanjundappa A, Chu HB, Smith BL, Grimsley BR, Hohmann SE, Vasquez J Jr, Metzger C, Henry CL, Ali MM, Mixon TA, Das TS, Gable DR, Eidt JF, Banerjee S. Rosol ZP, et al. Among authors: das ts. Am J Cardiol. 2025 Sep 15;251:38-45. doi: 10.1016/j.amjcard.2025.05.011. Epub 2025 May 15. Am J Cardiol. 2025. PMID: 40381900
There are unresolved questions regarding indications and outcomes of endovascular below-the-knee (BTK) interventions in patients with symptomatic peripheral artery disease (PAD) in real-world clinical practice. ...Majority (62.8%) of the BTK interventions were perfo …
There are unresolved questions regarding indications and outcomes of endovascular below-the-knee (BTK) interventions in patients with …
Value-Based Interventions for Lower Extremity Peripheral Vascular Interventions.
Altin SE, Box LC, Das T, Feldman DN, Jayasuriya S, Klein AJ, Latif F, Li J, Parikh SA, Secemsky EA, Swaminathan RV; SCAI 2022 Think Tank Peripheral Consortium; Boutin E, Canorea-Vega F, Chakrabarti AK, Hasegawa J, Howie N, Kohler T, Lauridsen HM, Perez O, Rangwala N, Schicchi M, Taber M, Venditto J, Wimberger J, Zinn L. Altin SE, et al. Among authors: das t. J Soc Cardiovasc Angiogr Interv. 2023 Jan 4;2(1):100533. doi: 10.1016/j.jscai.2022.100533. eCollection 2023 Jan-Feb. J Soc Cardiovasc Angiogr Interv. 2023. PMID: 39132519 Free PMC article. No abstract available.
Endovascular Treatment of Infrainguinal Peripheral Artery Disease With Stent Versus Nonstent Strategies in the XLPAD Registry.
Banerjee S, Fernandez Vazquez D, Liu YL, Sayfo S, Jeong M, Rosol ZP, Gupta A, Bruneman BM, Weideman SG, Adelman KS, Tsai S, Abdullah S, Chu HB, Smith BL, Grimsley BR, Hohmann SE, Vasquez J Jr, Metzger C, Henry CL, Ali MM, Mixon TA, Das TS, Gable DR, Eidt JF. Banerjee S, et al. Among authors: das ts. Am J Cardiol. 2025 Aug 1;248:58-66. doi: 10.1016/j.amjcard.2025.04.002. Epub 2025 Apr 8. Am J Cardiol. 2025. PMID: 40209973
We analyzed 12-month cumulative incidence of major adverse cardiac and vascular events (MACVE), a composite outcome of all-cause death, nonfatal myocardial infarction, stroke, lower limb revascularization and any amputation in patients treated with clinically indicated stent or n …
We analyzed 12-month cumulative incidence of major adverse cardiac and vascular events (MACVE), a composite outcome of all-cause death, nonf …
Safety and Efficacy of Radial Artery Access for Peripheral Vascular Intervention: A Single-Center Experience.
Sayfo S, Salih M, Moubarak G, Ibrahim R, Apala D, Das T, Banerjee S, Potluri S. Sayfo S, et al. Among authors: das t. Am J Cardiol. 2024 Sep 1;226:59-64. doi: 10.1016/j.amjcard.2024.06.025. Epub 2024 Jun 28. Am J Cardiol. 2024. PMID: 38945347
Of 491 PVI, 156 (31.8%) were performed through the RA. Anatomical locations for intervention were the femoral (44.8%), iliac (31.1%), popliteal (9.6%) peroneal (2.7%), tibial (9.9%), and subclavian (1.9%) arteries. ...Periprocedural complication rate was 3.84%, of which ac …
Of 491 PVI, 156 (31.8%) were performed through the RA. Anatomical locations for intervention were the femoral (44.8%), iliac (31.1%), …
Infrainguinal lesion-specific device choices: round-table discussion.
Das TS, Beregi JP, Garcia LA, Abul-Khoudoud O, Laird JR, Lumsden AB, Lyden SP, Mewissen MW, Shimshak TM. Das TS, et al. J Endovasc Ther. 2006 Feb;13 Suppl 2:II60-71. doi: 10.1177/15266028060130S210. J Endovasc Ther. 2006. PMID: 16472011 No abstract available.
Clinical Outcomes of Non-Stent-Based Interventions for Symptomatic Below-the-Knee Peripheral Artery Disease in the Excellence in Peripheral Artery Disease (XLPAD) Registry.
Sayfo S, Rosol ZP, Vazquez DF, Mamawala M, Bruneman BM, Weideman SG, Adelman KS, Jeong M, Ramanan B, Tsai S, Shammas NW, Monteleone PP, Nanjundappa A, Chu HB, Smith BL, Grimsley BR, Hohmann SE, Vasquez J Jr, Metzger C, Das TS, Gable DR, Eidt JF, Banerjee S. Sayfo S, et al. Among authors: das ts. Am J Cardiol. 2024 Oct 1;228:38-47. doi: 10.1016/j.amjcard.2024.07.016. Epub 2024 Aug 5. Am J Cardiol. 2024. PMID: 39111561
Nonstent treatment for BTK PAD with concomitant FP intervention leads to high procedural success and similar rates of 1-year MALE compared with isolated BTK intervention. Condensed Abstract: The vast majority of below-the-knee (BTK) peripheral artery disease (PAD) …
Nonstent treatment for BTK PAD with concomitant FP intervention leads to high procedural success and similar rates of 1-year MALE com …
Solid state, pulsed-wave 355 nm UV laser atherectomy debulking in the treatment of infrainguinal peripheral arterial disease: The Pathfinder Registry.
Das TS, Shammas NW, Yoho JA, Martinez-Clark P, Ramaiah V, Leon LR, Pacanowski JP, Tai Z, Ali V, Arslan B, Rundback J. Das TS, et al. Catheter Cardiovasc Interv. 2024 May;103(6):949-962. doi: 10.1002/ccd.31023. Epub 2024 Apr 2. Catheter Cardiovasc Interv. 2024. PMID: 38566525
AIMS: The Pathfinder multicenter registry was initiated to evaluate the safety and efficacy of the 355 nm laser atherectomy system in a real-world setting for the treatment of de novo, re-stenotic and in-stent restenosis (ISR) lesions in infrainguinal arteries of patients with pe …
AIMS: The Pathfinder multicenter registry was initiated to evaluate the safety and efficacy of the 355 nm laser atherectomy system in a real …
The REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of Hypertension.
Weber MA, Kirtane AJ, Weir MR, Radhakrishnan J, Das T, Berk M, Mendelsohn F, Bouchard A, Larrain G, Haase M, Diaz-Cartelle J, Leon MB. Weber MA, et al. Among authors: das t. JACC Cardiovasc Interv. 2020 Feb 24;13(4):461-470. doi: 10.1016/j.jcin.2019.10.061. JACC Cardiovasc Interv. 2020. PMID: 32081240 Free article. Clinical Trial.
BACKGROUND: A blood pressure-reducing effect of renal denervation has been difficult to isolate in clinical investigations. METHODS: REDUCE HTN: REINFORCE (Renal Denervation Using the Vessix Renal Denervation System for the Treatment of Hypertension) was a randomized, sham …
BACKGROUND: A blood pressure-reducing effect of renal denervation has been difficult to isolate in clinical investigations. METHODS: …
Optimal therapeutic approaches to femoropopliteal artery intervention.
Das T. Das T. Catheter Cardiovasc Interv. 2004 Sep;63(1):21-30. doi: 10.1002/ccd.20063. Catheter Cardiovasc Interv. 2004. PMID: 15343563 Review.
Optimal therapy requires understanding the available options including exercise programs, pharmacologic medical therapy, surgery and interventional endovascular therapy. Rapidly advancing endovascular technology for enabling safe intervention in complex, long occlus …
Optimal therapy requires understanding the available options including exercise programs, pharmacologic medical therapy, surgery and inte …
30 results